These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 28903339)
1. ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways. Liu XL; Zhang XT; Meng J; Zhang HF; Zhao Y; Li C; Sun Y; Mei QB; Zhang F; Zhang T Oncotarget; 2017 Aug; 8(33):54265-54276. PubMed ID: 28903339 [TBL] [Abstract][Full Text] [Related]
2. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
3. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway. Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286 [TBL] [Abstract][Full Text] [Related]
4. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545 [TBL] [Abstract][Full Text] [Related]
5. ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway. Zhao QY; Ju F; Wang ZH; Ma XZ; Zhao H Int J Clin Exp Med; 2015; 8(9):15498-505. PubMed ID: 26629040 [TBL] [Abstract][Full Text] [Related]
6. ING5 overexpression upregulates miR-34c-5p/Snail1 to inhibit EMT and invasion of lung cancer cells. Yang J; Liu X; Sun Y; Zhang X; Zhao Y; Zhang H; Mei Q; Meng J; Zhang F; Zhang T Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):809-817. PubMed ID: 37249332 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway. Gao W; Han J Biomed Pharmacother; 2018 Feb; 98():265-270. PubMed ID: 29272787 [TBL] [Abstract][Full Text] [Related]
8. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
9. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581 [TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
11. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway. Wang Y; Tan J; Li J; Chen H; Wang W Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285 [TBL] [Abstract][Full Text] [Related]
12. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
13. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297 [TBL] [Abstract][Full Text] [Related]
14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
15. The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy. Zhao S; Zhao ZJ; He HY; Wu JC; Ding XQ; Yang L; Jia N; Li ZJ; Zheng HC Oncotarget; 2017 Aug; 8(34):56558-56568. PubMed ID: 28915612 [TBL] [Abstract][Full Text] [Related]
16. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359 [TBL] [Abstract][Full Text] [Related]
17. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
18. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer. Kim MS; Lee WS; Jeong J; Kim SJ; Jin W Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594 [TBL] [Abstract][Full Text] [Related]
19. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671 [TBL] [Abstract][Full Text] [Related]
20. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. Bhat FA; Sharmila G; Balakrishnan S; Arunkumar R; Elumalai P; Suganya S; Raja Singh P; Srinivasan N; Arunakaran J J Nutr Biochem; 2014 Nov; 25(11):1132-1139. PubMed ID: 25150162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]